WallStreetZenWallStreetZen

NASDAQ: RAPP
Rapport Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Rapport Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RAPP annual revenue was $0.0, with N/A growth year-over-year.

RAPP revenue history

Current Revenue
$0.0
Current Earnings
-$78.3M
Current Profit Margin
0%

Be the first to know when RAPP announces revenue.

RAPP Revenue History By Year

RAPP Yearly RevenueRAPP RevenueRAPP ChangeRAPP Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Rapport Therapeutics Revenue FAQ

What was RAPP's revenue last quarter?

Rapport Therapeutics (NASDAQ: RAPP) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Rapport Therapeutics's revenue was $0.00.

What was Rapport Therapeutics's revenue in 2024?

Rapport Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Rapport Therapeutics make in a day?

Based on Rapport Therapeutics annual revenue for the past two years, RAPP makes an average of $0.00 per day.

What was Rapport Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Rapport Therapeutics's revenue has grown null year over year. Rapport Therapeutics's revenue in the past year totaled $0.00.

How much does Rapport Therapeutics make in a year?

Rapport Therapeutics's revenue by year for the past two years is:
  • Rapport Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Rapport Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.